6 research outputs found
U wave: an Important Noninvasive Electrocardiographic Diagnostic Marker
Study of U waves exemplifies important clinical role of noninvasive electrocardiography in modern cardiology. Present article highlights significance of U waves with a clinical case and also summarizes in brief the history of the same
Racing heart and pounding neck: Classic clinical sign revisited
The present report describes āFrog signā due to prominent jugular pulsations in the neck. This is seen in case of paroxysmal atrioventricular nodal reentrant tachycardia
Endothelial nitric oxide synthase (eNOS) gene polymorphism (Glu298asp) and nitric oxide (NO) levels in patients with ST-segment elevation myocardial infarction (STEMI)
Background: Genetic polymorphism in endothelial Nitric Oxide Synthase (eNOS) are associated with occurrence of multiple cardiovascular diseases (CVDs). Methods: This study included 300 young ST-segment elevation myocardial infarction (STEMI) patients and 300 healthy controls. STEMI patients were divided into two groups: premature coronary artery disease [CAD] (STEMI40 years of age). Genetic polymorphisms in the eNOS gene (894G/T) was evaluated in both subjects and controls. Plasma levels of nitric oxide (NO) were estimated for both patients as well as controls. Results: Mean age of the study population was 49.7Ā Ā±Ā 9.2 years with premature CAD being present in 58 (19.3Ā %) patients. No significant difference at genotypic (PĀ =Ā 0.589, odds ratio (OR)Ā =Ā 0.9, 95Ā % CIĀ =Ā 0.6ā1.6) and allelic level (PĀ =Ā 0.173, ORĀ =Ā 1.2, 95Ā % CIĀ =Ā 0.9ā1.4) was observed between STEMI patients and healthy controls. Genotype 894Ā TT had significantly higher frequency in STEMI patients >40 years (PĀ =Ā 0.047, OR: 2.5; 95Ā % CIĀ =Ā 1.0ā6.0). No significant difference at genotypic (PĀ =Ā 0.279) and allelic level (PĀ =Ā 0.493) was observed between premature CAD (STEMI age 40 years of age (P=Ā 0.001). Conclusion: There was significant association of eNOS gene polymorphism Glu298Asp with STEMI patientsĀ >Ā 40 years. However, this association was not observed in premature CAD patients. Lower levels of NO in STEMI patients >40 years suggests its potential role as a marker of CVD
Tumor necrosis factor-alphaĀ ā308G/A gene polymorphism and novel biomarker profiles in patients with Takayasu arteritis
Background: Takayasu arteritis (TA) is an idiopathic chronic inflammatory disease of the aorta and its branches, leading to stenosis, occlusion, and aneurysmal dilatation. Tumor necrosis factor-alpha (TNF-Ī±) is a cytokine with pleomorphic actions and plays a pivotal role in inflammation; the serum level of TNF-Ī± is genetically determined. However, the literature lacks adequate information on the association of TNF-Ī± polymorphisms with TA. Hence, the present study investigates the contribution of TNF-Ī± polymorphism toward the complex etiology of TA. Methods: A cross-sectional study was performed in 87 patients with TA and 90 controls. A promoter region polymorphism of TNF-Ī±, rs1800629Ā G/A, orĀ ā308G/A was genotyped in all the study subjects followed by a caseācontrol association study. Furthermore, to understand the biomarker profile, levels of specific markers such as erythrocyte sedimentation rate, serum high-sensitivity C-reactive protein, interleukin-18, interleukin-6, and TNF-Ī± were measured in all the study subjects. Results: All the inflammatory markers were significantly higher in the TA patients than in the controls. The genetic study (available for 57Ā TA patients and 36 controls) revealed that the TNF-Ī±Ā ā308A allele was overrepresented in the TA patients (12% vs 7%). The TNF-Ī±Ā ā308A allele correlated with the increased TNF-Ī± levels, but it could not attain significance because of a small sample size. Conclusion: The TNF-Ī±Ā ā308G/A polymorphism is associated with TNF-Ī± levels in Indian population, which might have implications for clinical risk stratification and treatment. The different TNF-Ī± gene promoter polymorphism might contribute to the molecular pathogenesis of TA. However, further study of the underlying mechanism is warranted. Keywords: Takayasu arteritis, Biomarkers, Tumor necrosis factor-alpha, Gene polymorphis
COVID-19 infected ST-Elevation myocardial infarction in India (COSTA INDIA)
Objective: To find out differences in the presentation, management and outcomes of COVID-19 infected STEMI patients compared to age and sex-matched non-infected STEMI patients treated during the same period. Methods: This was a retrospective multicentre observational registry in which we collected data of COVID-19 positive STEMI patients from selected tertiary care hospitals across India. For every COVID-19 positive STEMI patient, two age and sex-matched COVID-19 negative STEMI patients were enrolled as control. The primary endpoint was a composite of in-hospital mortality, re-infarction, heart failure, and stroke. Results: 410 COVID-19 positive STEMI cases were compared with 799 COVID-19 negative STEMI cases. The composite of death/reinfarction/stroke/heart failure was significantly higher among the COVID-19 positive STEMI patients compared with COVID-19 negative STEMI cases (27.1% vs 20.7% p valueĀ =Ā 0.01); though mortality rate did not differ significantly (8.0% vs 5.8% p valueĀ =Ā 0.13). Significantly lower proportion of COVID-19 positive STEMI patients received reperfusion treatment and primary PCI (60.7% vs 71.1% p value=< 0.001 and 15.4% vs 23.4% p valueĀ =Ā 0.001 respectively). Rate of systematic early PCI (pharmaco-invasive treatment) was significantly lower in the COVID-19 positive group compared with COVID-19 negative group. There was no difference in the prevalence of high thrombus burden (14.5% and 12.0% p valueĀ =Ā 0.55 among COVID-19 positive and negative patients respectively) Conclusions: In this large registry of STEMI patients, we did not find significant excess in in-hospital mortality among COVID-19 co-infected patients compared with non-infected patients despite lower rate of primary PCI and reperfusion treatment, though composite of in-hospital mortality, re-infarction, stroke and heart failure was higher